Toll Free: 1-888-928-9744
Published: Dec, 2015 | Pages:
34 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
Genervon Biopharmaceuticals, LLC - Product Pipeline Review - 2015 Summary Global Markets Direct's, 'Genervon Biopharmaceuticals, LLC - Product Pipeline Review - 2015', provides an overview of the Genervon Biopharmaceuticals, LLC's pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Genervon Biopharmaceuticals, LLC's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Genervon Biopharmaceuticals, LLC including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Genervon Biopharmaceuticals, LLC's human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Genervon Biopharmaceuticals, LLC's pipeline products Reasons to buy - Evaluate Genervon Biopharmaceuticals, LLC's strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Genervon Biopharmaceuticals, LLC in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Genervon Biopharmaceuticals, LLC's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Genervon Biopharmaceuticals, LLC and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Genervon Biopharmaceuticals, LLC - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope - Explore the dormant and discontinued projects of Genervon Biopharmaceuticals, LLC and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents
Table of Contents 2 List of Tables 4 List of Figures 4 Genervon Biopharmaceuticals, LLC Snapshot 5 Genervon Biopharmaceuticals, LLC Overview 5 Key Information 5 Key Facts 5 Genervon Biopharmaceuticals, LLC - Research and Development Overview 6 Key Therapeutic Areas 6 Genervon Biopharmaceuticals, LLC - Pipeline Review 8 Pipeline Products by Stage of Development 8 Pipeline Products - Monotherapy 9 Genervon Biopharmaceuticals, LLC - Pipeline Products Glance 10 Genervon Biopharmaceuticals, LLC - Clinical Stage Pipeline Products 10 Phase II Products/Combination Treatment Modalities 10 Phase I Products/Combination Treatment Modalities 11 Genervon Biopharmaceuticals, LLC - Early Stage Pipeline Products 12 Preclinical Products/Combination Treatment Modalities 12 Genervon Biopharmaceuticals, LLC - Drug Profiles 13 GM-602 13 Product Description 13 Mechanism of Action 13 R&D Progress 13 GM-604 14 Product Description 14 Mechanism of Action 14 R&D Progress 14 GM-608 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 GM-631 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 GM-603 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 GM-605 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 GM-607 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 GM-632 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 GM-1020 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 GM-606 22 Product Description 22 Mechanism of Action 22 R&D Progress 22 GM-609 23 Product Description 23 Mechanism of Action 23 R&D Progress 23 GM-641 24 Product Description 24 Mechanism of Action 24 R&D Progress 24 Genervon Biopharmaceuticals, LLC - Pipeline Analysis 25 Genervon Biopharmaceuticals, LLC - Pipeline Products by Target 25 Genervon Biopharmaceuticals, LLC - Pipeline Products by Route of Administration 26 Genervon Biopharmaceuticals, LLC - Pipeline Products by Molecule Type 27 Genervon Biopharmaceuticals, LLC - Pipeline Products by Mechanism of Action 28 Genervon Biopharmaceuticals, LLC - Recent Pipeline Updates 29 Genervon Biopharmaceuticals, LLC - Locations And Subsidiaries 32 Genervon Biopharmaceuticals, LLC - Locations And Subsidiaries 32 Head Office 32 Appendix 33 Methodology 33 Coverage 33 Secondary Research 33 Primary Research 33 Expert Panel Validation 33 Contact Us 33 Disclaimer 34
List of Tables
Genervon Biopharmaceuticals, LLC, Key Information 5 Genervon Biopharmaceuticals, LLC, Key Facts 5 Genervon Biopharmaceuticals, LLC - Pipeline by Indication, 2015 7 Genervon Biopharmaceuticals, LLC - Pipeline by Stage of Development, 2015 8 Genervon Biopharmaceuticals, LLC - Monotherapy Products in Pipeline, 2015 9 Genervon Biopharmaceuticals, LLC - Phase II, 2015 10 Genervon Biopharmaceuticals, LLC - Phase I, 2015 11 Genervon Biopharmaceuticals, LLC - Preclinical, 2015 12 Genervon Biopharmaceuticals, LLC - Pipeline by Target, 2015 25 Genervon Biopharmaceuticals, LLC - Pipeline by Route of Administration, 2015 26 Genervon Biopharmaceuticals, LLC - Pipeline by Molecule Type, 2015 27 Genervon Biopharmaceuticals, LLC - Pipeline Products by Mechanism of Action, 2015 28 Genervon Biopharmaceuticals, LLC - Recent Pipeline Updates, 2015 29
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.